ManagementParadise.com - Worlds Leading Management Portal. Online MBA | Classroom to Boardroom and Beyond
 
  Articles Details
Print Email  Add to briefcase

Cancer Generics Market Analysis

by Bharat Book Bureau on Wednesday 29 February 2012, 10:47 AM | Category: Press Releases| View: 711 views
 
 
Advertisements
 

Cancer has emerged as one of the major causes of death globally and has made the pharmaceutical & biotech companies proactive to foray research & development to develop new therapies for its treatment. With increasing cancer incidences and competition in the healthcare industry around the world, the cancer market represents a lucrative sector for the generic players around the world due to the fact that price erosion is significantly lower than the other segments.


 


 According to our new research report, “Cancer Generics Market Analysis”, the global cancer generics market is anticipated to grow at a CAGR of around 27% during 2010-2014. Market growth will be driven by upcoming anti-cancer blockbuster drugs patent expirations and the rising drugs bill that will encourage payers to address the barriers to generics access in order to control costs. As per our research, oncology drugs worth around US$10 Billion are expected to lose patent rights in the US by 2011. As the governments and private players have stepped in the industry across various geographical locations, the future prospects of the market shows immense opportunities to tap on.

http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/cancer-generics-market-analysis.html

 


 Our thorough study on the industry indicates that the Global Cancer generics drugs industry has witnessed a number of product launches and mergers & acquisitions in the past few years. The main focus of the companies has been to introduce effective and quality products in the market so that it gains a worldwide acceptance. With new markets and new products for generics manufacturers within the cancer market, it is anticipated that a harsh environment for companies focusing on novel cancer treatments is about to come. However, within the cancer market, there remains a high level of unmet need, and novel products demonstrating improved clinical attributes to any degree that would be expected to capture the market share from older generic drugs.

business market research

 


 On the competitive front, Teva & Hospira are presently the global market leader in cancer generics drugs market. Meanwhile, some Indian companies are also using their experiences within the deregulated markets to produce dossiers and products suited for the regulated markets.


 


 The report provides extensive information and rational analysis of the global cancer generics drugs market. It has thoroughly examined current market drivers, industrial developments, and competitive landscapes to enable clients understand the market structure and its progress in the coming years. The report also provides an insight into different marketed products along with pipeline analysis to present an overview of the developments taking place in the global cancer generics drugs industry. Further, a review of product innovations and recent industry activity has also been covered in the report.


 


 

List of Tables:
 

Table 6-1: List of Online Pharmacy Chains Selling Generic Arimidex


 Table 6-2: Cost Comparison of Generic & Branded Arimidex


 Table 6-3: List of Online Pharmacy Chains Selling Generic Bicalutamide


 Table 6-4: Cost Comparison of Generic & Branded Casodex


 Table 6-5: List of Online Pharmacy Chains Selling Generic Exemestane


 Table 6-6: Cost Comparison of Generic & Branded Exemestane


 Table 6-7: List of Online Pharmacy Chains Selling Generic Letrozole


 Table 6-8: Cost Comparison of Generic & Branded Letrozole


 Table 6-9: List of Online Pharmacy Chains Selling Generic Leucovorin Calcium


 Table 6-10: Cost Comparison of Generic & Branded Leucovorin Calcium


 Table 6-11: List of Online Pharmacy Chains Selling Generic Megestrol Acetate


 


 For more information kindly visit :
 
Cancer Generics Market Analysis

 


 Or


 


 Bharat Book Bureau


 Tel: +91 22 27810772 / 27810773


 Fax: + 91 22 27812290


 Email:

info@bharatbook.com

 Website:

www.bharatbook.com

 Follow us on twitter:

http://twitter.com/#!/Sandhya3B
Advertisements
Print-Friendly Version Email to a Friend
 
Related to Cancer Generics Market Analysis
 
 
 
 
 
 
STATS
 
Total articles: 5472
    Total Categories: 22
    Updated in Last Week: 9
LOGIN
 
   Login Id
   Password
  Forgot Password?
    
   
SEARCH ARTICLE
 
  Enter Keywords
 
CATEGORIES
 
    Banking and Finance
    Campus Articles
    Economy
INVITE FRIENDS
 
Invite your Friends, your Colleagues, your Group Members, your Seniors, your Team mates...and others.
 
 
Advertisements
 
spacer gif
Management Paradise
spacer gif
arrow gif About Us
Press
Jobs
Buy a Book
Kartik Raichura
spacer gif
spacer gif
spacer gif
Legal
spacer gif
spacer gif Terms & Conditions
spacer gif Privacy Policy
spacer gif Disclaimer
spacer gif Copyrights
spacer gif Contact Us
spacer gif
spacer gif
spacer gif
Help
spacer gif
spacer gif Getting Started
Support
FAQs
Tour
Feedback
Partners

MBA B School Blog

MBA Buy Entrance Exam Forms

MBA BMS Blog

MBA MBA Blog

MBA BMM Network

MBA Your Link Here

Follow
       
   

 

Copyright 2004 - 2014 Management Paradise. Site Developed by Available.co.in